Biodesix, Inc.
NASDAQ:BDSX · NASDAQ Global Market
+$2.04 today
Vol 0.13M · Avg 0.06M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+213.04%
Period High
$19.40
Period Low
$5.01
Latest
$16.81
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Mersana Therapeutics, Inc.
MRSN
$145.36M
OnKure Therapeutics, Inc.
NASDAQ:OKUR
$58.39M
Xilio Therapeutics, Inc.
NASDAQ:XLO
$58.15M
PDS Biotechnology Corporation
NASDAQ:PDSB
$50.97M
INmune Bio, Inc.
INMB
$36.16M
Aligos Therapeutics, Inc.
ALGS
$32.93M
Skye Bioscience, Inc.
SKYE
$25.03M
Wellgistics Health, Inc.
WGRX
$8.71M
VolitionRx Limited
VNRX
$8.55M
Inotiv, Inc.
NOTV
$2.79M
What is the latest BDSX filing?
The latest filing shown is 424B3 dated Jun 1, 2026.
How many recent filings does BDSX have?
Intrinsic Alpha currently shows 20 recent filings for BDSX.
Explore More
Continue the stock analysis
Jump to another research area for this company.